South-Eastern Asia vs Sweden: Proportion of the target population who received the final dose of
South-Eastern Asia
51.0%
in 2024
Sweden
87.0%
in 2024
South-Eastern Asia rank
13th
Sweden rank
16th
Proportion of the target population who received the final dose of over time
- South-Eastern Asia
- Sweden
How they compare
Sweden currently reports 87.0% against 51.0% in South-Eastern Asia, a difference of 36.0%.
That makes Sweden's figure about 1.7 times South-Eastern Asia's.
Across all 9 years both countries report, Sweden has been ahead every year.
South-Eastern Asia ranks 13th and Sweden ranks 16th of 35 groups.
Sweden has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | South-Eastern Asia | Sweden | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 8.2% | 75.0% | 66.8% | Sweden |
| 2020s | 19.2% | 85.6% | 66.4% | Sweden |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, South-Eastern Asia or Sweden?
- Sweden, at 87.0% against 51.0% in South-Eastern Asia as of 2024.
- What is the difference in proportion of the target population who received the final dose of between South-Eastern Asia and Sweden?
- 36.0%, with Sweden ahead.
- How many years of comparable data are there for South-Eastern Asia and Sweden?
- 9 years are reported by both, from 2016 to 2024.
- How do South-Eastern Asia and Sweden rank globally for proportion of the target population who received the final dose of?
- South-Eastern Asia ranks 13th and Sweden ranks 16th of 35 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.